» Articles » PMID: 32390798

LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models

Overview
Specialty Molecular Biology
Date 2020 May 12
PMID 32390798
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Merosin deficient Congenital Muscular Dystrophy (MDC1A), or LAMA2-related muscular dystrophy (LAMA2-RD), is a recessive disorder resulting from mutations in the gene, encoding for the alpha-2 chain of laminin-211. The disease is predominantly characterized by progressive muscular dystrophy affecting patient motor function and reducing life expectancy. However, LAMA2-RD also comprises a developmentally-associated dysmyelinating neuropathy that contributes to the disease progression, in addition to brain abnormalities; the latter often underappreciated. In this brief review, we present data supporting the impact of peripheral neuropathy in the LAMA2-RD phenotype, including both mouse models and human studies. We discuss the molecular mechanisms underlying nerve abnormalities and involved in the laminin-211 pathway, which affects axon sorting, ensheathing and myelination. We conclude with some final considerations of consequences on nerve regeneration and potential therapeutic strategies.

Citing Articles

A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy.

Enzmann C, Steiner L, Pospieszny K, Zweier C, Plattner K, Baumann D J Neuromuscul Dis. 2024; 11(5):1021-1033.

PMID: 39213089 PMC: 11380305. DOI: 10.3233/JND-240023.


Identification of compound heterozygous variants: a case report.

Ying Y, Ye J, Shen J, Chen G, Jiang K Transl Pediatr. 2024; 13(6):1001-1006.

PMID: 38984033 PMC: 11228908. DOI: 10.21037/tp-24-62.


Meta-analysis of differential gene expression in lower motor neurons isolated by laser capture microdissection from post-mortem ALS spinal cords.

Swindell W Front Genet. 2024; 15:1385114.

PMID: 38689650 PMC: 11059082. DOI: 10.3389/fgene.2024.1385114.


Merosin-deficient congenital muscular dystrophy type 1a: detection of variants in Vietnamese patients.

Tran V, Nguyen N, Tran L, Thi Le P, Tran A, Pham T Front Genet. 2023; 14:1183663.

PMID: 37388928 PMC: 10301838. DOI: 10.3389/fgene.2023.1183663.


Nerve pathology is prevented by linker proteins in mouse models for -related muscular dystrophy.

Reinhard J, Porrello E, Lin S, Pelczar P, Previtali S, Ruegg M PNAS Nexus. 2023; 2(4):pgad083.

PMID: 37038437 PMC: 10082391. DOI: 10.1093/pnasnexus/pgad083.


References
1.
Seo S, Min S, Bae H, Roh D, Kang H, Roh S . A laminin-2-derived peptide promotes early-stage peripheral nerve regeneration in a dual-component artificial nerve graft. J Tissue Eng Regen Med. 2012; 7(10):788-800. DOI: 10.1002/term.1468. View

2.
Di Muzio A, De Angelis M, Di Fulvio P, Ratti A, Pizzuti A, Stuppia L . Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy. Muscle Nerve. 2003; 27(4):500-6. DOI: 10.1002/mus.10326. View

3.
Davies J, Wang L, Garcia-Oroz L, Cook L, Vacher C, ODonovan D . Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med. 2005; 11(6):672-7. DOI: 10.1038/nm1242. View

4.
Yurchenco P, McKee K . Linker Protein Repair of LAMA2 Dystrophic Neuromuscular Basement Membranes. Front Mol Neurosci. 2020; 12:305. PMC: 6923227. DOI: 10.3389/fnmol.2019.00305. View

5.
Law P, Saito A, Fleischer S . Ultrastructural changes in muscle and motor end-plate of the dystrophic mouse. Exp Neurol. 1983; 80(2):361-82. DOI: 10.1016/0014-4886(83)90289-3. View